Therapeutic options following pneumonectomy in non-small cell lung cancer

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

ABSTRACT: Introduction: Pneumonectomy can be considered the most appropriate treatment for lung cancer that cannot be removed by lesser resection on. Areas covered: Therapeutic options following pneumonectomy may be required at least in 3 different scenarios: 1) an early approach due to acute surgical complications 2) a late approach due to chronic surgical complications 3) an integrated radio-chemotherapeutic adjuvant approach for advanced stages. In this review we focused on these three settings with particular emphasis to surgical approach as well as to alternative options. Expert commentary: Pneumonectomy itself does not preclude postoperative additional treatments, if needed, to maximize oncological results and to manage potential short or long term complications. However, as pneumonectomy puts a significant physiological stress on the respiratory and circulatory systems, the benefits and risks of pneumonectomy should be compared with those of alternative, non-resectional treatment modalities.

Original languageEnglish
Pages (from-to)919-925
Number of pages7
JournalExpert Review of Respiratory Medicine
Volume10
Issue number8
DOIs
Publication statusPublished - Aug 2 2016

Fingerprint

Pneumonectomy
Non-Small Cell Lung Carcinoma
Therapeutics
Physiological Stress
Cardiovascular System
Radio
Respiratory System
Lung Neoplasms

Keywords

  • adjuvant chemotherapy
  • Pneumonectomy
  • radiotherapy
  • single-lung surgery
  • thermal ablation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health

Cite this

Therapeutic options following pneumonectomy in non-small cell lung cancer. / Petrella, Francesco; Spaggiari, Lorenzo.

In: Expert Review of Respiratory Medicine, Vol. 10, No. 8, 02.08.2016, p. 919-925.

Research output: Contribution to journalReview article

@article{e426c9b817ff4181b29168d91454ebe7,
title = "Therapeutic options following pneumonectomy in non-small cell lung cancer",
abstract = "ABSTRACT: Introduction: Pneumonectomy can be considered the most appropriate treatment for lung cancer that cannot be removed by lesser resection on. Areas covered: Therapeutic options following pneumonectomy may be required at least in 3 different scenarios: 1) an early approach due to acute surgical complications 2) a late approach due to chronic surgical complications 3) an integrated radio-chemotherapeutic adjuvant approach for advanced stages. In this review we focused on these three settings with particular emphasis to surgical approach as well as to alternative options. Expert commentary: Pneumonectomy itself does not preclude postoperative additional treatments, if needed, to maximize oncological results and to manage potential short or long term complications. However, as pneumonectomy puts a significant physiological stress on the respiratory and circulatory systems, the benefits and risks of pneumonectomy should be compared with those of alternative, non-resectional treatment modalities.",
keywords = "adjuvant chemotherapy, Pneumonectomy, radiotherapy, single-lung surgery, thermal ablation",
author = "Francesco Petrella and Lorenzo Spaggiari",
year = "2016",
month = "8",
day = "2",
doi = "10.1080/17476348.2016.1188694",
language = "English",
volume = "10",
pages = "919--925",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "8",

}

TY - JOUR

T1 - Therapeutic options following pneumonectomy in non-small cell lung cancer

AU - Petrella, Francesco

AU - Spaggiari, Lorenzo

PY - 2016/8/2

Y1 - 2016/8/2

N2 - ABSTRACT: Introduction: Pneumonectomy can be considered the most appropriate treatment for lung cancer that cannot be removed by lesser resection on. Areas covered: Therapeutic options following pneumonectomy may be required at least in 3 different scenarios: 1) an early approach due to acute surgical complications 2) a late approach due to chronic surgical complications 3) an integrated radio-chemotherapeutic adjuvant approach for advanced stages. In this review we focused on these three settings with particular emphasis to surgical approach as well as to alternative options. Expert commentary: Pneumonectomy itself does not preclude postoperative additional treatments, if needed, to maximize oncological results and to manage potential short or long term complications. However, as pneumonectomy puts a significant physiological stress on the respiratory and circulatory systems, the benefits and risks of pneumonectomy should be compared with those of alternative, non-resectional treatment modalities.

AB - ABSTRACT: Introduction: Pneumonectomy can be considered the most appropriate treatment for lung cancer that cannot be removed by lesser resection on. Areas covered: Therapeutic options following pneumonectomy may be required at least in 3 different scenarios: 1) an early approach due to acute surgical complications 2) a late approach due to chronic surgical complications 3) an integrated radio-chemotherapeutic adjuvant approach for advanced stages. In this review we focused on these three settings with particular emphasis to surgical approach as well as to alternative options. Expert commentary: Pneumonectomy itself does not preclude postoperative additional treatments, if needed, to maximize oncological results and to manage potential short or long term complications. However, as pneumonectomy puts a significant physiological stress on the respiratory and circulatory systems, the benefits and risks of pneumonectomy should be compared with those of alternative, non-resectional treatment modalities.

KW - adjuvant chemotherapy

KW - Pneumonectomy

KW - radiotherapy

KW - single-lung surgery

KW - thermal ablation

UR - http://www.scopus.com/inward/record.url?scp=84978501322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978501322&partnerID=8YFLogxK

U2 - 10.1080/17476348.2016.1188694

DO - 10.1080/17476348.2016.1188694

M3 - Review article

AN - SCOPUS:84978501322

VL - 10

SP - 919

EP - 925

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 8

ER -